Question 1

What is the catalog number for CEP-18770 50mg?

Accepted Answer

The catalog number for CEP-18770 50mg is A11145-50.

Question 2

What sizes are available for CEP-18770 50mg?

Accepted Answer

CEP-18770 50mg is available in the following size(s): 50 mg.

Question 3

Is CEP-18770 50mg in stock?

Accepted Answer

CEP-18770 50mg is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is this product suitable for live cell imaging?

Accepted Answer

Suitability for live cell imaging depends on the specific reagent and conjugate used. Check the datasheet for imaging-specific validation, or contact us for guidance.

Question 5

Is this product covered by a money-back guarantee?

Accepted Answer

Yes, we guarantee a full refund or store credit if this product arrives damaged beyond usability, or has a genuine performance issue under proper usage and storage, provided you report it immediately with evidence. Claims after the expiration date or due to improper storage after receipt are excluded.

Question 6

Can this product be used for diagnostic or therapeutic purposes?

Accepted Answer

No. This product, like all items we supply, is intended for research laboratory use only and must not be used for diagnostics, therapeutics, treatment, or consumption by humans or animals.

CEP-18770 50mg

Product Specifications

CAS Number

Frequently Asked Questions

Explore Other Products

DNAH10OS Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)

TSGA2, Control Peptide (Testis-specific Gene A2 Protein, TSA2, Radial Spoke Head 1 Homolog, RSPH1, Cancer/testis Antigen 79, CT79, Male Meiotic Metaphase Chromosome-associated Acidic Protein, Meichroacidin, RSP44, RSPH10A, FLJ32753, MGC126568, MGC141927)

Lentiviral mouse Cacng2 shRNA (UAS) - Lentiviral mouse Cacng2 shRNA (UAS, GFP) (100)

COL18A1, ID (COL18A1, Collagen alpha-1(XVIII) chain, Endostatin)

COL18A1, ID (COL18A1, Collagen alpha-1(XVIII) chain, Endostatin)

Apobec2 sgRNA CRISPR/Cas9 All-in-One Lentivector (Mouse) (Target 2)